Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Thumbnail Image
Download
Name

1-s2.0-S0092867421004323-main.pdf

Description
Correction
Size

134.23 KB

Format

Adobe PDF

Checksum (MD5)

68197b2e76c72255b1f4d3a3de8510b1

Thumbnail Image
Download
Name

Stephanopoulos_The mTORC1.pdf

Size

1.54 MB

Format

Adobe PDF

Checksum (MD5)

d4a2322da2887f94b16aa51c1bed67a9

Author(s)
Csibi, Alfred
•
Fendt, Sarah-Maria
•
Li, Chenggang
•
Poulogiannis, George
•
Choo, Andrew Y.
•
Chapski, Douglas J.
•
Jeong, Seung Min
•
Dempsey, Jamie M.
•
Parkhitko, Andrey
•
Morrison, Tasha
more
Date Issued
May 2013
Journal
Cell
Publisher
Elsevier
Citation
Csibi, Alfred, Sarah-Maria Fendt, Chenggang Li, George Poulogiannis, Andrew Y. Choo, Douglas J. Chapski, Seung Min Jeong, et al. “The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4.” Cell 153, no. 4 (May 2013): 840–854. © 2013 Elsevier Inc.
Version
Final published version
Abstract
Proliferating mammalian cells use glutamine as a source of nitrogen and as a key anaplerotic source to provide metabolites to the tricarboxylic acid cycle (TCA) for biosynthesis. Recently, mammalian target of rapamycin complex 1 (mTORC1) activation has been correlated with increased nutrient uptake and metabolism, but no molecular connection to glutaminolysis has been reported. Here, we show that mTORC1 promotes glutamine anaplerosis by activating glutamate dehydrogenase (GDH). This regulation requires transcriptional repression of SIRT4, the mitochondrial-localized sirtuin that inhibits GDH. Mechanistically, mTORC1 represses SIRT4 by promoting the proteasome-mediated destabilization of cAMP-responsive element binding 2 (CREB2). Thus, a relationship between mTORC1, SIRT4, and cancer is suggested by our findings. Indeed, SIRT4 expression is reduced in human cancer, and its overexpression reduces cell proliferation, transformation, and tumor development. Finally, our data indicate that targeting nutrient metabolism in energy-addicted cancers with high mTORC1 signaling may be an effective therapeutic approach.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/91506
DOI of Published Version
https://doi.org/10.1016/j.cell.2013.04.023
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.